Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Current Assets (2016 - 2025)

Historic Current Assets for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $301.1 million.

  • AtriCure's Current Assets rose 1181.79% to $301.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $301.1 million, marking a year-over-year increase of 1181.79%. This contributed to the annual value of $267.8 million for FY2024, which is 59.34% up from last year.
  • AtriCure's Current Assets amounted to $301.1 million in Q3 2025, which was up 1181.79% from $271.3 million recorded in Q2 2025.
  • In the past 5 years, AtriCure's Current Assets registered a high of $301.1 million during Q3 2025, and its lowest value of $195.7 million during Q3 2021.
  • Over the past 5 years, AtriCure's median Current Assets value was $245.2 million (recorded in 2024), while the average stood at $242.8 million.
  • Data for AtriCure's Current Assets shows a peak YoY increase of 13484.07% (in 2021) and a maximum YoY decrease of 3607.68% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows AtriCure's Current Assets stood at $196.1 million in 2021, then increased by 9.76% to $215.2 million in 2022, then increased by 23.71% to $266.2 million in 2023, then increased by 0.59% to $267.8 million in 2024, then grew by 12.43% to $301.1 million in 2025.
  • Its Current Assets was $301.1 million in Q3 2025, compared to $271.3 million in Q2 2025 and $251.5 million in Q1 2025.